Vanguard Capital Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-117,568
Closed -$85.8K 4137
2026
Q1
$85.8K Buy
+117,568
New +$535K ﹤0.01% 3875

Other funds holding RVPH

Vanguard Capital Management's RVPH Position: Q2 2026 in Review

Vanguard Capital Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 117,568 shares — an estimated $85.8K sold.

Vanguard Capital Management first reported a position in RVPH in Q1 2026 and held it in 1 quarter. The position peaked at $85.8K in Q1 2026. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

  • Vanguard Capital Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
  • Vanguard Capital Management sold 117,568 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $85.8K.
  • Vanguard Capital Management first reported a position in REVIVA PHARMA HLDGS INC in Q1 2026 and held it in 1 quarter.
  • Vanguard Capital Management's REVIVA PHARMA HLDGS INC position peaked at $85.8K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.